Compare DBVT & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DBVT | CPAC |
|---|---|---|
| Founded | 2002 | 1949 |
| Country | France | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.4M | 905.9M |
| IPO Year | N/A | 2012 |
| Metric | DBVT | CPAC |
|---|---|---|
| Price | $17.61 | $10.26 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | ★ $31.75 | $10.15 |
| AVG Volume (30 Days) | ★ 611.1K | 204.0K |
| Earning Date | 10-28-2025 | 02-13-2026 |
| Dividend Yield | N/A | ★ 5.38% |
| EPS Growth | N/A | ★ 20.27 |
| EPS | N/A | ★ 0.15 |
| Revenue | $5,502,000.00 | ★ $601,081,883.00 |
| Revenue This Year | $1,768.71 | $9.96 |
| Revenue Next Year | $1,028.88 | $1.70 |
| P/E Ratio | ★ N/A | $13.84 |
| Revenue Growth | N/A | ★ 6.18 |
| 52 Week Low | $3.30 | $5.10 |
| 52 Week High | $26.19 | $11.30 |
| Indicator | DBVT | CPAC |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 66.28 |
| Support Level | $16.49 | $10.04 |
| Resistance Level | $19.62 | $10.39 |
| Average True Range (ATR) | 1.49 | 0.34 |
| MACD | -0.50 | -0.04 |
| Stochastic Oscillator | 11.76 | 25.00 |
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.